Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HER2+ Metastatic Breast Cancer (MBC) × Patient Navigation × Breast × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 12 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Intraductal, Noninfiltrating 2 Rectal Neoplasms 1 HER2+ Metastatic Breast Cancer (MBC) 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

neratinib 1 Patient Navigation 1 Lapatinib 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06983691 2026-03-06

Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

Duke University

Phase NA Not yet recruiting

HER2+ Metastatic Breast Cancer (MBC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡